COVID-19 Antigen Test Awarded Regulatory Approval in Brazil

The PerkinElmer® COVID-19 Antigen Test has been approved by the National Sanitary Surveillance Agency of Brazil (ANVISA) as a Class III in vitro diagnostic (IVD) device. This approval authorizes the sale, distribution, and use of PerkinElmer’s 15-minutes antigen test in Brazil for the qualitative detection of SARS-CoV-2, with nasal or nasopharyngeal swabs. The PerkinElmer® COVID-19 Antigen test is an accurate and efficient product to screen for the presence of COVID-19.

July 28th, 2021|Categories: 2019-nCoV|

Detecting B.1.617 VOC

Identifying the Delta VOC (B.1.617) with the NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit | On May 10, 2021, the World Health Organization (WHO) designated the delta variant a variant of concern (VOC), the fourth variant to receive this designation.

May 17th, 2021|Categories: 2019-nCoV, NGS|

Confirmation of SARS-CoV-2 RT-PCR Results

Verifying the Presence of the SARS-CoV-2 in Positive RT-PCR Samples | The PerkinElmer® New Coronavirus Nucleic Acid Detection kit has been identified as having the highest sensitivity of the commercially available COVID-19 diagnostic kits. The purpose of this study is to use Next Generation Sequencing (NGS) of samples with a range of Ct values to verify the presence of the SARS-CoV-2 genome.

March 8th, 2021|Categories: 2019-nCoV, qPCR, RT-PCR|

Recent Posts



Recent Tweets

Go to Top